Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Embecta Corp.

Get SEC filing alerts via email and in your feed for Embecta Corp.

EMBC

Embecta Corp.

About Embecta Corp.

Embecta Corp. is a global medical device company specializing in diabetes management solutions, including pen needles, syringes, and safety injection devices. Its products serve millions worldwide, primarily targeting insulin users and healthcare providers. The company emphasizes innovation, quality, and regulatory compliance, operating through a broad manufacturing and distribution network. It competes on product quality, clinical innovation, and cost, focusing on expanding access and advancing diabetes care.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Embecta Corp.

1
1
Embecta Corp. Embecta Corp. Reports 14.4% Revenue Decline and Net Loss in Q2 Fiscal 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Embecta Corp. Embecta Corp. Reports Slight Revenue Decline but Significant Profitability Improvements for Q4 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Embecta Corp. Embecta Corp. Reports $1.08 Billion Revenue Decline and Increased Operating Income for Fiscal Year Ending September 30, 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Embecta Corp. Embecta Corp. Reports Q3 2025 Financial Results with Significant Net Income Increase

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Embecta Corp. Embecta Corp. Reports Revenue Decline and Increased Operating Income in Q2 FY 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Embecta Corp. Embecta Corp. Reports 5.6% Revenue Decline and Zero Net Income in Q1 FY 2025

Via official filing (AI summary) | over 1 year ago | 0 comments